Farmacología
Departamento
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Instituto de Salud Carlos III (6)
2022
-
Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome
eLife, Vol. 11
-
NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches
International Journal of Molecular Sciences, Vol. 23, Núm. 13
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2019
-
Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics
Translational Psychiatry, Vol. 9, Núm. 1
2017
-
CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal
Biological Psychiatry, Vol. 81, Núm. 7, pp. 625-634
-
Oxytocin in animal models of autism spectrum disorder
Developmental Neurobiology, Vol. 77, Núm. 2, pp. 202-213